These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7484490)

  • 1. Xamoterol improves the control of chronic atrial fibrillation in elderly patients.
    Lawson-Matthew PJ; McLean KA; Dent M; Austin CA; Channer KS
    Age Ageing; 1995 Jul; 24(4):321-5. PubMed ID: 7484490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
    Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM
    Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.
    Lewis RV; McMurray J; McDevitt DG
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):1-6. PubMed ID: 2468920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.
    Lancet; 1988 Mar; 1(8584):489-93. PubMed ID: 2893916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of xamoterol and verapamil on ventricular rate regulation in patients with chronic atrial fibrillation.
    Lundström T; Moor E; Rydén L
    Am Heart J; 1992 Oct; 124(4):917-23. PubMed ID: 1356311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.
    Molajo AO; Coupe MO; Bennett DH
    Br Heart J; 1984 Oct; 52(4):392-5. PubMed ID: 6148092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.
    Channer KS; James MA; MacConnell T; Rees JR
    Br J Clin Pharmacol; 1994 Jan; 37(1):53-7. PubMed ID: 7908532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
    Sorensen EV; Sterndorff B; Andersen MF; Faergeman O
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):203-9. PubMed ID: 2577283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
    Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
    Waller DG; Webster J; Sykes CA; Bhalla KK; Wray R
    Eur Heart J; 1989 Nov; 10(11):1003-10. PubMed ID: 2574108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure.
    Klein W; Eber B; Rotman B
    Angiology; 1992 Apr; 43(4):281-6. PubMed ID: 1348403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
    Lancet; 1990 Jul; 336(8706):1-6. PubMed ID: 1694945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards improved control of atrial fibrillation.
    Channer KS; Papouchado M; James MA; Pitcher DW; Rees JR
    Eur Heart J; 1987 Feb; 8(2):141-7. PubMed ID: 3552679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation.
    Lewis RV; Laing E; Moreland TA; Service E; McDevitt DG
    Eur Heart J; 1988 Mar; 9(3):279-83. PubMed ID: 3289931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved control of atrial fibrillation with combined pindolol and digoxin therapy.
    James MA; Channer KS; Papouchado M; Rees JR
    Eur Heart J; 1989 Jan; 10(1):83-90. PubMed ID: 2702970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
    Marlow HF
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.
    McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG
    Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.